Whole-body periodic acceleration modifies experimental asthma in sheep

William M. Abraham, Ashfaq Ahmed, Irakli Serebriakov, Isabel T. Lauredo, Jorge Bassuk, Jose A. Adams, Marvin A. Sackner

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Rationale: Nitric oxide is released from vascular endothelium in response to increased pulsatile shear stress. Nitric oxide inhibits mast cell activation and is antiinflammatory and therefore might be protective in asthma. Objectives: We determined if a noninvasive motion platform that imparts periodic sinusoidal inertial forces to the whole body along the spinal axis (pGz) causing release of endothelial nitric oxide modulates experimental asthma in sheep. Methods: Allergic sheep were untreated (control) or were treated with pGz alone or after receiving intravenously the nitric oxide synthase inhibitor N w-nitro-L-arginine methyl ester (L-NAME) before aerosol challenge with Ascaris suum, and the effect on antigen-induced airway responses was determined. Bronchoalveolar lavage cells obtained 6 h after antigen challenge were analyzed for nuclear factor-κB (NF-κB) activity in the respective groups. Results: pGz treatment for 1 h before antigen challenge reduced the early airway response and blocked the late airway response but did not prevent the antigen-induced airway hyperresponsiveness 24 h after challenge. Administration of L-NAME before pGz completely reversed this protection, whereas L-NAME alone did not affect the antigen-induced responses. NF-κB activity was 1.9- and 1.8-fold higher in the control and L-NAME + pGz groups, respectively, compared with pGz-treated animals. Extending the pGz treatment to twice daily for 3 d and then 1 h before antigen challenge blocked the early and late airway responses, the 24-h airway hyperresponsiveness, and the airway inflammatory cell response. Conclusion: Whole-body pGz modulates allergen-induced airway responses in allergic sheep.

Original languageEnglish
Pages (from-to)743-752
Number of pages10
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume174
Issue number7
DOIs
StatePublished - Oct 1 2006
Externally publishedYes

Fingerprint

Sheep
Asthma
NG-Nitroarginine Methyl Ester
Antigens
Nitric Oxide
Ascaris suum
Vascular Endothelium
Bronchoalveolar Lavage
Aerosols
Mast Cells
Nitric Oxide Synthase
Allergens
Anti-Inflammatory Agents
Therapeutics

Keywords

  • Animal models
  • Asthma therapy
  • Nitric oxide
  • Noninvasive periodic acceleration

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Abraham, W. M., Ahmed, A., Serebriakov, I., Lauredo, I. T., Bassuk, J., Adams, J. A., & Sackner, M. A. (2006). Whole-body periodic acceleration modifies experimental asthma in sheep. American Journal of Respiratory and Critical Care Medicine, 174(7), 743-752. https://doi.org/10.1164/rccm.200601-048OC

Whole-body periodic acceleration modifies experimental asthma in sheep. / Abraham, William M.; Ahmed, Ashfaq; Serebriakov, Irakli; Lauredo, Isabel T.; Bassuk, Jorge; Adams, Jose A.; Sackner, Marvin A.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 174, No. 7, 01.10.2006, p. 743-752.

Research output: Contribution to journalArticle

Abraham, WM, Ahmed, A, Serebriakov, I, Lauredo, IT, Bassuk, J, Adams, JA & Sackner, MA 2006, 'Whole-body periodic acceleration modifies experimental asthma in sheep', American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 7, pp. 743-752. https://doi.org/10.1164/rccm.200601-048OC
Abraham, William M. ; Ahmed, Ashfaq ; Serebriakov, Irakli ; Lauredo, Isabel T. ; Bassuk, Jorge ; Adams, Jose A. ; Sackner, Marvin A. / Whole-body periodic acceleration modifies experimental asthma in sheep. In: American Journal of Respiratory and Critical Care Medicine. 2006 ; Vol. 174, No. 7. pp. 743-752.
@article{01ab430bf1d448a2856f383f843782a8,
title = "Whole-body periodic acceleration modifies experimental asthma in sheep",
abstract = "Rationale: Nitric oxide is released from vascular endothelium in response to increased pulsatile shear stress. Nitric oxide inhibits mast cell activation and is antiinflammatory and therefore might be protective in asthma. Objectives: We determined if a noninvasive motion platform that imparts periodic sinusoidal inertial forces to the whole body along the spinal axis (pGz) causing release of endothelial nitric oxide modulates experimental asthma in sheep. Methods: Allergic sheep were untreated (control) or were treated with pGz alone or after receiving intravenously the nitric oxide synthase inhibitor N w-nitro-L-arginine methyl ester (L-NAME) before aerosol challenge with Ascaris suum, and the effect on antigen-induced airway responses was determined. Bronchoalveolar lavage cells obtained 6 h after antigen challenge were analyzed for nuclear factor-κB (NF-κB) activity in the respective groups. Results: pGz treatment for 1 h before antigen challenge reduced the early airway response and blocked the late airway response but did not prevent the antigen-induced airway hyperresponsiveness 24 h after challenge. Administration of L-NAME before pGz completely reversed this protection, whereas L-NAME alone did not affect the antigen-induced responses. NF-κB activity was 1.9- and 1.8-fold higher in the control and L-NAME + pGz groups, respectively, compared with pGz-treated animals. Extending the pGz treatment to twice daily for 3 d and then 1 h before antigen challenge blocked the early and late airway responses, the 24-h airway hyperresponsiveness, and the airway inflammatory cell response. Conclusion: Whole-body pGz modulates allergen-induced airway responses in allergic sheep.",
keywords = "Animal models, Asthma therapy, Nitric oxide, Noninvasive periodic acceleration",
author = "Abraham, {William M.} and Ashfaq Ahmed and Irakli Serebriakov and Lauredo, {Isabel T.} and Jorge Bassuk and Adams, {Jose A.} and Sackner, {Marvin A.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1164/rccm.200601-048OC",
language = "English",
volume = "174",
pages = "743--752",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "7",

}

TY - JOUR

T1 - Whole-body periodic acceleration modifies experimental asthma in sheep

AU - Abraham, William M.

AU - Ahmed, Ashfaq

AU - Serebriakov, Irakli

AU - Lauredo, Isabel T.

AU - Bassuk, Jorge

AU - Adams, Jose A.

AU - Sackner, Marvin A.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Rationale: Nitric oxide is released from vascular endothelium in response to increased pulsatile shear stress. Nitric oxide inhibits mast cell activation and is antiinflammatory and therefore might be protective in asthma. Objectives: We determined if a noninvasive motion platform that imparts periodic sinusoidal inertial forces to the whole body along the spinal axis (pGz) causing release of endothelial nitric oxide modulates experimental asthma in sheep. Methods: Allergic sheep were untreated (control) or were treated with pGz alone or after receiving intravenously the nitric oxide synthase inhibitor N w-nitro-L-arginine methyl ester (L-NAME) before aerosol challenge with Ascaris suum, and the effect on antigen-induced airway responses was determined. Bronchoalveolar lavage cells obtained 6 h after antigen challenge were analyzed for nuclear factor-κB (NF-κB) activity in the respective groups. Results: pGz treatment for 1 h before antigen challenge reduced the early airway response and blocked the late airway response but did not prevent the antigen-induced airway hyperresponsiveness 24 h after challenge. Administration of L-NAME before pGz completely reversed this protection, whereas L-NAME alone did not affect the antigen-induced responses. NF-κB activity was 1.9- and 1.8-fold higher in the control and L-NAME + pGz groups, respectively, compared with pGz-treated animals. Extending the pGz treatment to twice daily for 3 d and then 1 h before antigen challenge blocked the early and late airway responses, the 24-h airway hyperresponsiveness, and the airway inflammatory cell response. Conclusion: Whole-body pGz modulates allergen-induced airway responses in allergic sheep.

AB - Rationale: Nitric oxide is released from vascular endothelium in response to increased pulsatile shear stress. Nitric oxide inhibits mast cell activation and is antiinflammatory and therefore might be protective in asthma. Objectives: We determined if a noninvasive motion platform that imparts periodic sinusoidal inertial forces to the whole body along the spinal axis (pGz) causing release of endothelial nitric oxide modulates experimental asthma in sheep. Methods: Allergic sheep were untreated (control) or were treated with pGz alone or after receiving intravenously the nitric oxide synthase inhibitor N w-nitro-L-arginine methyl ester (L-NAME) before aerosol challenge with Ascaris suum, and the effect on antigen-induced airway responses was determined. Bronchoalveolar lavage cells obtained 6 h after antigen challenge were analyzed for nuclear factor-κB (NF-κB) activity in the respective groups. Results: pGz treatment for 1 h before antigen challenge reduced the early airway response and blocked the late airway response but did not prevent the antigen-induced airway hyperresponsiveness 24 h after challenge. Administration of L-NAME before pGz completely reversed this protection, whereas L-NAME alone did not affect the antigen-induced responses. NF-κB activity was 1.9- and 1.8-fold higher in the control and L-NAME + pGz groups, respectively, compared with pGz-treated animals. Extending the pGz treatment to twice daily for 3 d and then 1 h before antigen challenge blocked the early and late airway responses, the 24-h airway hyperresponsiveness, and the airway inflammatory cell response. Conclusion: Whole-body pGz modulates allergen-induced airway responses in allergic sheep.

KW - Animal models

KW - Asthma therapy

KW - Nitric oxide

KW - Noninvasive periodic acceleration

UR - http://www.scopus.com/inward/record.url?scp=33749451807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749451807&partnerID=8YFLogxK

U2 - 10.1164/rccm.200601-048OC

DO - 10.1164/rccm.200601-048OC

M3 - Article

C2 - 16858016

AN - SCOPUS:33749451807

VL - 174

SP - 743

EP - 752

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 7

ER -